Open AccessCombination treatment with cisplatin, paclitaxel and olaparib has synergistic and dose reduction potential in ovarian cancer cells
Author(s) -
Jianwen Gao,
Zehua Wang,
Jiayu Fu,
A. Jisaihan,
Yuko Ohno,
Congjian Xu
Publication year - 2021
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2021.10367
Subject(s) - olaparib , ovarian cancer , paclitaxel , cisplatin , cancer research , medicine , oncology , cancer , chemotherapy , cancer cell , pharmacology , biology , poly adp ribose polymerase , biochemistry , polymerase , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom